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LETTER TO THE EDITOR L
Canadian clinical guidelines for periodic eye examinations in 
children aged 0-5. Impact on patients
As an optometry student, the very first patient I encountered in the dis-
pensing clinic was a 3-year-old boy with high hyperopia who was receiv-
ing his first spectacles (+8.50). As ‘patient A’ gazed wide-eyed at the pre-
viously-unseen wonders of the clinic reception area, he started to dance 
and exclaim “I’m happy! I’m happy!”. His mother’s eyes welled up as she 
explained to me that she was very concerned; her son had developed motor 
and language delays over the past year. He had completed developmental 
and hearing assessments before anyone suggested testing his vision. Based 
on his behaviour upon receiving his new spectacles, if visual impairment 
was not the sole cause of these delays, it certainly was a contributor. 
More recently, I refracted ‘patient B’, an 8-year-old boy with a similar un-
corrected refractive error. He too showed no outward indication of visual 
dysfunction. He had a history of poor reading, inattention and disruptive 
behaviour at school. He had developed mild bilateral refractive amblyopia, 
but could eke out passing levels of visual acuity with monocular testing. 
Patient B was of lower socioeconomic status and his parents were not pro-
active; he may well have had additional reasons for his educational difficul-
ties, but clearly the system had failed to provide optimal vision care. What 
if the new guidelines of the Joint Clinical Practice Guideline Expert Com-
mittee of the Canadian Association of Optometrists and the Canadian Oph-
thalmological Society, had been implemented when I had seen these pa-
tients? Patient A would have had the same, non-optimal outcome: a modest 
delay in identification of his vision problem and likely the ability to catch 
up, if there were no other developmental issues. Patient B would likely have 
benefited from improved childhood development (from age 3 onward) and 
from optimal vision during his early primary school years.
Both children would have received greater benefit if they had undergone 
refraction before 1 year of age, as recommended in the AOA guidelines 
currently used throughout North America. Although this is anecdotal evi-
dence, it illustrates the benefit of following, guidelines that provide a higher 
standard of care than those adopted by the Canadian Committee. 
Encouragingly, I’ve observed a groundswell of progress in awareness, and 
in the prompt and appropriate referral of young children for visual assess-
ment, particularly those in higher-risk categories. I have also observed 
some progress in parental awareness. Perhaps there will be fewer cases of 
strabismus ‘waiting’ until the child can read letters before an eye examina-
tion is attempted. Will these new guidelines roll back this current progress? 
I encourage Canadian optometrists to download and read the AOA Opto-
metric Clinical Practice Guideline: Pediatric Eye and Vision Examination,1 
for comprehensive guidance regarding not only the frequency of testing but 
also testing strategies and advice for parents. 
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